Search clinical trials for: VALSARTAN HYDROCHLOROTHIAZIDE

Total 833 results

EMS

Not yet recruiting

Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

Arterial Hypertension
University of Abuja
Imperial College London; University College Hospital, Ibadan; University of Nairobi and other collaborators

Completed

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans (Creole)

Hypertension

Nigeria
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
University Medical Centre Ljubljana

Completed

Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan

Myocardial Infarction

Slovenia
Mustafa Kemal University
Novartis Pharmaceuticals

Completed

Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

Hypertension | Left Ventricular Hypertrophy

Turkey
Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Hypertension

China
Pfizer

Completed

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Healthy Participants

United States
Azidus Brasil

Completed

Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

Healthy Subjects

Brazil
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older (TELSYS)

Hypertension
Boehringer Ingelheim

Completed

An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

Hypertension

Korea, Republic of
University of Pisa

Unknown

Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy (PURITY)

Glucose Metabolism Disorders | Renal Function Disorder

Italy
Boehringer Ingelheim

Completed

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

Hypertension
Pfizer

Completed

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Hypertension | Blood Pressure, High

United States
Novartis

Completed

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension (ATTAIN)

Hypertension

United States
EMS

Withdrawn

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

Hypertension | Dyslipidemia
HK inno.N Corporation

Completed

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

Healthy

Korea, Republic of
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
HK inno.N Corporation

Completed

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Hypertension With Hyperlipidemia
Medical Center Alkmaar

Unknown

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients (AIRCo)

Colon Carcinoma

Netherlands
University of Sao Paulo General Hospital
InCor Heart Institute

Recruiting

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. (ANSWER-HF)

Chagas Cardiomyopathy

Brazil
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Isolated Systolic Hypertension in the Elderly and Very Elderly

Isolated Systolic Hypertension

Germany
Medical University of Vienna

Unknown

Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve

Optic; Neuritis, With Demyelination

Austria
Boehringer Ingelheim

Completed

A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

Hypertension

Italy, Germany, Netherlands, France, South Africa, Belgium, Denmark, Finland, Ireland, Spain
Merck Sharp & Dohme LLC

Completed

Hyzaar Asia HEAALTH (0954A-950)

Hypertension
Yining Huang

Unknown

Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE)

Cerebral Small Vessel Diseases

China
Boehringer Ingelheim

Completed

Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Treatment of HYpertension: Morning Versus Evening (THYME)

Essential Hypertension

Netherlands
Boehringer Ingelheim
Astellas Pharma Inc

Completed

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

Hypertension

Japan
University Hospital Tuebingen

Withdrawn

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Type 2 Diabetes Mellitus (T2DM)

Germany
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

Hypertension
Sanofi

Completed

ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination (ACTUAL)

Hypertension

Brazil, Tunisia, Argentina, Egypt, Mexico, Peru, Morocco, Colombia, Guatemala, Venezuela, Lebanon, Algeria, Ecuador, Panama, Saudi Arabia, United Arab Emirates
Novartis

Completed

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Hypertension

China
Boryung Pharmaceutical Co., Ltd
Chonnam National University Hospital; Seoul National University Hospital; Kyungpook... and other collaborators

Completed

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
Novartis

Completed

A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

HYPERTENSION | HYPERCHOLESTEROLEMIA

United States
Novartis Pharmaceuticals

Completed

Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

Hypertension

Russian Federation
Novartis

Completed

A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Hypercholesterolemia | Essential Hypertension

Switzerland, Germany
University of Maryland, Baltimore
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Salt Loading and Thiazide Intervention Study (SALTI)

Hypertension

United States
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
HK inno.N Corporation

Completed

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Healthy
First Affiliated Hospital of Zhejiang University

Recruiting

Research on the Biological Mechanism of the Efficacy of Psychotherapy for Depression Based on the fNIRS

Depressive Disorder

China
Instituto Nacional de Cardiologia Ignacio Chavez
Boehringer Ingelheim laboratory

Not yet recruiting

" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "

Heart Failure | Congenital Heart Disease | Heart Failure With Reduced Ejection Fraction

Mexico
Samsung Medical Center

Recruiting

Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB (REVERSE-AR)

Aortic Valve Insufficiency

Korea, Republic of
JW Pharmaceutical

Completed

Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia (COCTAIL)

Hypertension | Dyslipidemia

Korea, Republic of
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

Healthy
Boehringer Ingelheim

Completed

Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

Healthy

3

Subscribe